IDEX IDEX Biometrics ASA

IDEX Biometrics Interim Report for the First Half of 2022

IDEX Biometrics Interim Report for the First Half of 2022

Oslo, Norway – 11 August 2022- IDEX Biometrics ASA’s interim report for the first half 2022, is enclosed with this notice.

A webcast presentation will be held by Vince Graziani, Chief Executive Officer, at 13:00 CET. The webcast can be viewed at the following link:

The interim report and the presentation shown in the webcast are available on the IDEX Biometrics website:

Commercial Update

During the second quarter of 2022, IDEX continued to make commercial progress with our fingerprint solution with three new commercial bank launches. Fintech companies and challenger banks seeking security for their clients and product differentiation have been adopters of biometric smart cards. In 2022 Rocker, Manager.one, Fidor and an issuing bank based in Turkey have launched, or will soon launch, biometric payment cards embedding IDEX Biometrics sensor solutions.  

We also entered into an important agreement with Linxens, the leading supplier of EMV® modules and interconnect technology, for the manufacturing of smart cards. Under the agreement, Linxens will bundle biometric solutions from IDEX with an EMV module and interconnect technology from Linxens providing card makers a complete, ready to assemble, solution for biometric smart cards.

Investment in the biometric payment card industry continues to grow, but widespread deployment of biometric cards by banks and issuers is taking longer than industry participants and analysts predicted. Banks cite several reasons for these delays with the ongoing chip shortage being the main culprit. Secure element chips for standard contactless payment cards are in short supply and many banks are delaying the introduction of new payment card products as a result. However, with consumer interest growing, issuer banks are introducing biometric payment cards to segments of their card portfolios. 2022 has become the year for initial scaling with segment launches, leading to a broader roll-out during 2023. 

Second Quarter and First Half Financial Performance

For the second quarter ended June 30, 2022, IDEX Biometrics recorded consolidated revenue of $1.1 million. Sequentially, second quarter revenue increased approximately 12% from the first quarter of 2022, reflecting the increased shipments to our primary customer in the payment card segment. By comparison, second quarter 2021 revenue was $697 thousand, for a year-over-year quarterly increase of 59%.

For the first half of 2022, the Company recorded consolidated revenue of $2.1 million, compared to $1.3 million for the same period in 2021, representing an increase of 59%.

Revenues in the second quarter increased both sequentially and year-over-year despite supply chain disruptions as a result of Covid-19 related restrictions in China that delayed shipments from one of our suppliers. As we had pre-ordered inventory in anticipation of longer lead times, our quarterly revenue was less negatively impacted than would otherwise been the case. In the second half of 2022, we expect our revenue figures to be negatively impacted as our shipments from our assembly subcontractor will most likely continue to be constrained.

The gross margin was 6.6% in the second quarter, and 18.5% for the first six months of 2022. Our margins were adversely impacted by several factors: Higher component prices have not yet been passed on to customers, manufacturing costs have not yet achieved high-volume level, product mix changes, and a write-off of inventory of a discontinued product.

Operating expenses increased in the second quarter and the first half of 2022 compared to same periods in 2021. Other than Cost of materials, the increase was primarily in Other operating expenses. The year-over-year increase is associated largely with higher marketing and sales costs, reflecting the expansion of our commercial activities.

In response to uncertainty around the timing of revenue as a result of the factors mentioned above, IDEX has implemented measures to contain operating expenses and the number of staff will be reduced during the second half of 2022.

Net loss for the second quarter of 2022 totaled ($9.2 million), in contrast to a net loss of ($7.2 million) for the second quarter of 2021, and a net loss of ($8.1 million) for the first quarter of 2022.

Net loss for the first half of 2022 totaled ($17.4 million), in contrast to a net loss of ($14.8 million) for the first half of 2021.

For further information contact:

Marianne Bøe, Head of Investor Relations

E-mail:

Tel:

Brett L. Perry, U.S. Investor Relations

E-mail:

Tel:

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal authentication for all.  We help people make payments, prove their identity, gain access to information, or unlock devices with the touch of a finger. We invent, engineer, and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

For more information, visit

TRADEMARK STATEMENT

IDEX, TrustedBio, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment



EN
11/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch